drugset / Trial / NCT06662396

A Study of Diltiazem With a Single Dose of MK-6552 in Healthy Adult Participants (MK-6552-007)

NCT06662396

Phase 1 Completed 14 enrolled Merck Sharp & Dohme LLC
NaSingle-groupOpen-labelBasic science

Summary

The main goal of this study is to learn what happens to MK-6552 in a person's body over time (a pharmacokinetic or PK study). Researchers want to know what happens to MK-6552 in healthy adults when a single dose of MK-6552 is given with multiple doses of diltiazem. The researchers believe that multiple doses of diltiazem will not affect the highest amount of MK-6552 in the blood.

Timeline

Start
2024-06-13
Primary completion
2024-09-27
Completion
2024-09-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Diltiazem Small molecule Oral
Subject MK-6552 Unknown Oral

Indications

No indication recorded.